key: cord-0721887-uv9p3mnn authors: Patel, B. V.; Haar, S.; Handslip, R.; Lee, T. M.-L.; Patel, S.; Hosking-Jervis, F.; Kelly, D.; Harston, A.; Sanderson, B.; Borgatta, B.; Tatham, K. C.; Welters, I.; Camporota, L.; Gordon, A. C.; Komorowski, M.; antcliffe, D.; Prowle, J. R.; Puthucheary, Z.; Faisal, A. A.; Evaluation, United Kingdom COVID-ICU National Service title: Natural history, trajectory, and management of mechanically ventilated COVID-19 patients in the United Kingdom. date: 2020-11-13 journal: nan DOI: 10.1101/2020.11.10.20226688 sha: 38219e2de3ef1b9f39ffa5e0e7fffabd4e3a0240 doc_id: 721887 cord_uid: uv9p3mnn Background. To date the description of mechanically ventilated patients with Coronavirus Disease 2019 (COVID-19) has focussed on admission characteristics with no consideration of the dynamic course of the disease. Here, we present a data-driven analysis of granular, daily data from a representative proportion of patients undergoing invasive mechanical ventilation (IMV) within the United Kingdom (UK) to evaluate the complete natural history of COVID-19. Methods. We included adult patients undergoing IMV within 48 hours of ICU admission with complete clinical data until death or ICU discharge. We examined factors and trajectories that determined disease progression and responsiveness to ARDS interventions. Our data visualisation tool is available as a web-based widget (https://www.CovidUK.ICU). Findings. Data for 623 adults with COVID-19 who were mechanically ventilated between 01 March 2020 and 31 August 2020 were analysed. Mortality, intensity of mechanical ventilation and severity of organ injury increased with severity of hypoxaemia. Median tidal volume per kg across all mandatory breaths was 5.6 [IQR 4.7-6.6] mL/kg based on reported body weight, but 7.0 [IQR 6.0-8.4] mL/kg based on calculated ideal body weight. Non-resolution of hypoxaemia over the first week of IMV was associated with higher ICU mortality (59.4% versus 16.3%; P<0.001). Of patients ventilated in prone position only 44% showed a positive oxygenation response. Non-responders to prone position show higher D-Dimers, troponin, cardiovascular SOFA, and higher ICU mortality (68.9% versus 29.7%; P<0.001). Multivariate analysis showed prone non-responsiveness being independently associated with higher lactate (hazard ratio 1.41, 95% CI 1.03-1.93), respiratory SOFA (hazard ratio 3.59, 95% CI 1.83-7.04); and cardiovascular SOFA score (hazard ratio 1.37, 95% CI 1.05-1.80). Interpretation. A sizeable proportion of patients with progressive worsening of hypoxaemia were also refractory to evidence-based ARDS strategies and showed a higher mortality. Strategies for early recognition and management of COVID19 patients refractory to conventional management strategies will be critical to improving future outcomes. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.10.20226688 doi: medRxiv preprint . preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; 1 0 a n a l y s i s o v e r t h e f i r s t 7 d a y s s h o w e d s t a t i s t i c a l l y s i g n i f i c a n t i n t e r a c t i o n s b e t w e e n g r o u p s i n r e s p i r a t o r y f a i l u r e i n d i c e s , c u m u l a t i v e f l u i d b a l a n c e , a c i d -b a s e s t a t u s , r e n a l f u n c t i o n , D -d i m e r , C R P a n d S O F A s c o r e ( F i g u r e 4 a n d T a b l e S 7 ) . M u l t i v a r i a t e r e g r e s s i o n s h o w e d t h a t i n c r e a s e d a g e , l o w e r s o d All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; 13 d y s f u n c t i o n ( t r o p o n i n a n d B N P ( B r a i n N a t r i u r e t i c P e p t i d e ) ) b e t w e e n p a t i e n t s t h a t s u r v i v e d a n d d i e d , t i m e s e r i e s m i x e d m o d e l a n a l y s i s s u g g e s t s s u r v i v o r s a l s o s h o w p r o g r e s s i v e r e d u c t i o n s i n C R P a n d n e u t r o p h i l s , i n a d d i t i o n t o r e s t o r a t i o n o f l y m p h o c y t e a n d p l a t e l e t c o u n t s . I n d e preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; 15 d e t e r i o r a t e o v e r t h e f i r s t 7 d a y s , r e s u l t i n g i n a s i g n i f i c a n t l y l o n g e r p e r i o d o f m e c h a n i c a l v e n t i l a t i o n t h a n n o n -C O V I D A R D S . S e c o n d l y , t h e t i m e s e r i e s a n a l y s e s o f l o n g i t u d i n a l d i s e a s e t r a j e c t o r y e m p h a s i s e s t h e i m p o r t a n c e o f r o u t i n e a n d f r e q u e n t a s s e s s m e n t o f i n f l a m m a t i o n , t h r o m b o s preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; 1 7 f r o m r e c o m m e n d e d p r e -C O V I D P E E P l a d d e r . D a t a p o i n t s a r e c o l o u r c o d e d b y D a y s a f t e r i n i t i a t i o n o f I M V ( s e e c o l o u r b a r i n t h e n e x t s u b -f i g u r e ) . ( D ) V i s u a l i s a t i o n o f t h e c h a n g e s i n P E E P a g a i n s t t h e c h a n g e i n P a O 2 / F i O 2 r a t i o . T h e c h a n g e s a r e m e a s u r e d a c r o s s t w o a d j a c e n t t i m e p o i n t s w i t h t h e P E E All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101 https://doi.org/10. /2020 2 0 T a b l e L e g e n d s T a b l e 1 -C l i n i c a l a n d p h y s i o l o g i c a l c h a r a c t e r i s t i c s , o u t c o m e s a n d i n t e r v e n t i o n s a c c o r d i n g t o s e v e r i t y o f h y p o x a e m i a o n a d m i s s i o preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.10.20226688 doi: medRxiv preprint 1 T a b l e S 1 3 -C l i n i c a l a n d p h y s i o l o g i c a l c h a r a c t e r i s t i c s , o u t c o m e s a n d i n t e r v e n t i o n s a c c o r d i n g t o I C U o u t c o m e . T a b l e S 1 4 -T i m e s e r i e s m i x e d m o d e l A N O V A a c c o r d i n g t o I C U o u t c o m All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. R e f e r e n c e s 1 G r a s s e l l i G , T o n e t t i T , P r o t t i A , e t a l . P a t h o p h y s i o l o g y o f C O V I D -1 9 -a s s o c i a t e d a c u t e r e s p i r a t o r y d i s t r e s s s y n d r o m e : a m u l t i c e n t r e p r o s p e c t i v e o b s e r v a t i o n a l s t u d preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.10.20226688 doi: medRxiv preprint 2 4 2 2 B o t t a M , T s o n a s A M , P i l l a y J , e t a l . V e n t i l a t i o n m a n a g e m e n t a n d c l i n i c a l o u t c o m e s i n i n v a s i v e l y v e n t i l a t e d p a t i e n t s w i t h C O V I D -1 9 ( P R o V E N T -C O V I D ) : a n a t i o n a l , m u l t i c e n t r e , o b s e r v a t i o n a l c o h o r All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this this version posted November 13, 2020. ; https://doi.org/10.1101/2020.11.10.20226688 doi: medRxiv preprint preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetu Figure 2 A B C All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetu Figure 3 A B All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetu Figure 4 A B All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetu All rights reserved. No reuse allowed without permission. preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetu Lactate mmol/L 159 (25.5%) Prone positioning 541 268 (49.5%) 59%) 119 6 (5.04%) Renal replacement therapy Therapeutic heparin 428 55 (12.9%)